Medicine and Dentistry
Cohort Analysis
95%
Nephropathy
92%
Kidney Function
89%
Proteinuria
75%
Prospective Cohort Study
75%
Chronic Kidney Disease
75%
Glomerular Filtration Rate
70%
End Stage Renal Disease
69%
Creatinine
68%
Renal Biopsy
64%
Nephrotic Syndrome
63%
Diabetic Nephropathy
60%
Disease
58%
Urinary System
53%
Immunoglobulin A Nephropathy
45%
Nephrology
44%
Lupus Nephritis
44%
All Cause Mortality
43%
Biopsy
39%
Hazard Ratio
39%
ANCA Associated Vasculitis
39%
Vasculitis
37%
Acute Kidney Injury
37%
Minimal Change Disease
37%
Retrospective Cohort Study
36%
Proportional Hazards Model
35%
Immunoglobulin G4
33%
Polycystic Kidney Disease
33%
Glomerulonephritis
32%
Neutrophil Cytoplasmic Antibody
31%
Cardiovascular System
31%
Pediatrics
30%
Microscopic Polyangiitis
30%
Pancreas Transplantation
30%
Myeloperoxidase
26%
Infection
25%
Spontaneous Remission
24%
Rapidly Progressive Glomerulonephritis
23%
Immunoglobulin
23%
Nephrosclerosis
23%
Prednisolone
22%
Pulmonary Hemorrhage
22%
Combined Therapy
22%
Lipoprotein Apheresis
22%
Low-Density Lipoprotein
22%
Membranous Glomerulonephritis
22%
Aortic Valve Stenosis
22%
Patient with Diabetes
22%
Febuxostat
22%
Plasma Exchange
22%
Cytapheresis
22%
Peritoneal Dialysis
22%
Glucocorticoid
21%
Survival Rate
20%
Hemoglobin A1c
19%
Immunosuppressive Treatment
19%
Graft Survival
19%
Corticosteroid Therapy
18%
Acute Lung Injury
17%
Combination Therapy
17%
Focal Segmental Glomerulosclerosis
16%
Leukapheresis
16%
Granulocytapheresis
16%
Serum Albumin
16%
Kidney Graft
15%
Apheresis
15%
Isotopes of Calcium
14%
Prospective Study
14%
Observational Study
14%
Elderly Patient
14%
Blood Purification
14%
Odds Ratio
14%
Renal Pathology
14%
Ischemic Heart Disease
14%
Diabetes Mellitus
14%
Hemodialysis
13%
Provocation Test
13%
Glucagon
13%
Interstitial Nephritis
13%
Fibrosis
13%
Acetic Acid Derivative
13%
Quality of Life
12%
Glomerulopathy
12%
Logistic Regression Analysis
12%
Diabetes
12%
Human Study
12%
COVID-19
12%
B Cell
12%
Hypercholesterolemia
12%
Continuous Ambulatory Peritoneal Dialysis
12%
Outpatient
12%
Chronicity
11%
Deterioration
11%
Cross Sectional Study
11%
Vitamin D Receptor
11%
Glomerulus Basement Membrane
11%
Renal Failure
11%
Tryptophan
11%
Intraperitoneal Drug Administration
11%
Hemoglobin Determination
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Prospective Cohort Study
89%
Disease
78%
Remission
77%
Chronic Kidney Failure
75%
Hemodialysis
65%
Nephrotic Syndrome
58%
All Cause Mortality
58%
Creatinine
49%
Acute Kidney Failure
48%
End Stage Renal Disease
48%
Cardiovascular Disease
48%
Vasculitis
44%
Combination Therapy
41%
Acute Lung Injury
39%
Infection
37%
Proteinuria
37%
Histone
33%
Alzheimer's Disease
33%
Ascites
33%
Kidney Disease
29%
Diabetic Nephropathy
29%
Neutrophil Cytoplasmic Antibody
27%
Inflammation
26%
Kidney Failure
25%
Serum Albumin
25%
C Reactive Protein
25%
Glomerulonephritis
24%
Biological Marker
24%
ANCA Associated Vasculitis
22%
Immunoglobulin G4
22%
Hyperuricemia
22%
Troponin T
22%
Brain Natriuretic Peptide
22%
Adverse Drug Reaction
22%
Cisplatin
22%
Lupus Erythematosus Nephritis
22%
Glucocorticoid
21%
Malignant Ascites
21%
Immunoglobulin A Nephropathy
21%
Membranous Glomerulonephritis
20%
Amyloid
19%
Immunosuppressive Agent
17%
Cause of Death
16%
Sepsis
16%
Myeloperoxidase
15%
Clinical Study
15%
Survival Rate
15%
Adverse Event
15%
Lung Hemorrhage
14%
Vitamin D Receptor
14%
Randomized Controlled Trial
14%
Focal Glomerulosclerosis
14%
Mortality Rate
14%
Mouse
14%
Renin
14%
Angiotensin
14%
Microscopic Polyangiitis
14%
Disease Activity
13%
Coronavirinae
13%
Antianemic Agent
13%
Prednisolone
12%
Adsorption
12%
Human Study
12%
Parathyroid Hormone
12%
Observational Study
12%
Ischemic Heart Disease
12%
Uric Acid
12%
Rapidly Progressive Glomerulonephritis
12%
Prospective Study
12%
Anemia
11%
Polysulfone
11%
Protein Glutamine Gamma Glutamyltransferase 2
11%
Albuminuria
11%
Nephrosclerosis
11%
Ferrous Sulfate
11%
Rheumatoid Arthritis
11%
Dapagliflozin
11%
Antihypertensive Agent
11%
Neutrophil Gelatinase Associated Lipocalin
11%
Plasmodium chabaudi
11%
Rodent Malaria
11%
Indican
11%
Thiamine
11%
Continuous Erythropoiesis Receptor Activator
11%
Recombinant Erythropoietin
11%
Transferrin Receptor
11%
Tolvaptan
11%
Cardiovascular Mortality
11%
Hydrogen Sulfide
11%
Sodium Hydrosulfide
11%
Tryptophan
11%
Octreotide
11%
Pasireotide
11%
Macroalbuminuria
11%
Hypotension
11%
Tumor Necrosis Factor Receptor
11%
Heart Disease
11%
Immune Checkpoint Inhibitor
11%
Paraprotein
11%
Keyphrases
Remission of Proteinuria
33%
Dialysis Initiation
27%
Minimal Change Disease
27%
Multicenter Cohort Study
24%
Prospective Cohort Study
24%
Japan
22%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
22%
Incident Dialysis Patients
22%
Hemodialysis
22%
Acute Kidney Injury
22%
Clinical Practice Guidelines
22%
Time to Remission
22%
Steroid-sensitive
22%
Confidence Interval
21%
Hemodialysis Patients
20%
Alzheimer's Disease
18%
Remission
18%
Nephrotic Syndrome
16%
All-cause Mortality
16%
Pediatric
14%
Blood Purification
14%
Infection-related Mortality
14%
Hazard Ratio
14%
Clinical Impact
13%
Removal System
13%
Adult Patients
12%
IgA Nephropathy (IgAN)
12%
Early Remission
12%
Vasculitis Damage Index
12%
End-stage Kidney Disease
12%
Vitamin D Receptor Activator
11%
Lipoprotein Apheresis
11%
Proteinuria
11%
Infection Risk
11%
Associated Vasculitis
11%
Antibody-associated
11%
Preoperative Hemoglobin
11%
Acute Kidney Injury Network Criteria
11%
Darbepoetin Alfa
11%
Dyslipidemia
11%
Brain Amyloid
11%
Japanese Adverse Drug Event Report (JADER)
11%
Primary Aldosteronism
11%
Primary Hyperparathyroidism (pHPT)
11%
Hemoglobin Level
11%
Unilateral Adrenalectomy
11%
IgG4-related Kidney Disease
11%
Cognitive State
11%
Outcome Analysis
11%
Early Dialysis
11%
Cholesterol
11%
Phosphorus Levels
11%
Synthetic Glycopeptides
11%
Ferrous Sulfate
11%
Ferric Citrate
11%
B-cell Depletion
11%
Hyperuricemia
11%
N-acetyl-L-tryptophan
11%
Plasmodium Chabaudi AS
11%
Uremic Sarcopenia
11%
Protein-bound Uremic Toxins
11%
Patients with Diabetes Mellitus
11%
NC Mice
11%
Reticulocyte Hemoglobin Content
11%
Hypochromic Red Blood Cells
11%
Serum Iron Level
11%
Racial Heterogeneity
11%
Transferrin Receptor 1 (TfR1)
11%
Sodium Zirconium Cyclosilicate
11%
HAT Therapy
11%
Committee Report
11%
Disease Registry
11%
Cellulose Beads
11%
Therapeutic System
11%
Alkyl Ligands
11%
Purifier
11%
H2S-producing Enzymes
11%
Hydrogen Sulfide
11%
Sodium Hydrosulfide
11%
H2S Donors
11%
N-glycosylation
11%
FcRI
11%
IgA1
11%
Giant Cell Arteritis
11%
Safety Outcomes
11%
Treatment-related
11%
Pasireotide
11%
Diabetic Foot
11%
Damage Accrual
11%
Octreotide
11%
Pancreatic Transplantation
11%
Future Hospital
11%
High-sensitivity Troponin I
11%
Peritoneal Dialysis Outcome
11%
Infrared Thermography
11%
Immunoadsorption
11%
Telomere Attrition
11%
Post-hoc Explanation
11%
Corticosteroid Therapy
11%
Elderly Onset
11%